Dipanjan Pan
Dipanjan Pan | |
|---|---|
| Nationality | American |
| Occupation(s) | Academic Entrepreneur |
| Academic background | |
| Alma mater | Indian Institute of Technology |
| Academic advisors | Karen L. Wooley |
| Academic work | |
| Institutions | Washington University in St. Louis
University of Illinois at Urbana-Champaign |
Dipanjan Pan is an Indian American academic who is the Dorothy Foehr Huck & J. Lloyd Huck Chair Professor in Nanomedicine at Pennsylvania State University.[1]
Early life and education
[edit]Dipanjan Pan was born in India.[2] He obtained his doctoral degree from the Indian Institute of Technology and subsequently joined Washington University in St. Louis.[3] There, he collaborated with Karen L. Wooley on investigating the utilization of self-assembled polymeric nanoparticles for targeted drug delivery applications.[3]
Career
[edit]Pan started his career in 2005 as an intellectual property analyst in chemistry at General Electric's John F. Welch Technology Centre.[4]
In 2007, he joined the Washington University School of Medicine in Saint Louis as a research instructor.[4][5] In 2010, he became an assistant professor in medicine and served until 2013, contributing to the field of cardiovascular research.[4][6]
In 2013, Pan joined the University of Illinois Urbana-Champaign as an assistant professor.[4]
In 2014, Pan co-founded InnSight Technology, a preclinical company, along with Leanne Labriola.[7] Two years later, in 2016, he co-founded KaloCyte, a company that has developed an artificial blood called Erythromer, with Allan Doctor and Philip Spinella.[8][9] He has served as a professor of radiology in the school of medicine, and professor of chemical and biochemical and environmental engineering at the University of Maryland, Baltimore County.[10][11]
Pan is the current head of the Pan Laboratory for Materials in Medicine.[12]
Research
[edit]His research focuses on the development and application of nanoscale materials and techniques for the diagnosis and treatment of various diseases, particularly cancer and cardiovascular disorders.[3]
In 2014, Pan and his team reported a novel method for inhibiting cancer cell growth using nanotechnology, as detailed in a paper presented at the American Chemical Society conference.[13] The preliminary research demonstrated success in impeding breast cancer and melanoma cell growth in laboratory settings by delivering a synthetic compound mimicking venom from bees, snakes, and scorpions.[13][14]
In 2015, Pan, Leanne Labriola, and other team members developed a portable sensor named OcuCheck that assesses ocular injuries through the quantification of vitamin C concentration in a patient's tears at the University of Illinois.[15]
In 2018, Pan and other researchers at the University of Illinois created a gel utilizing gold nanoparticles which has the capability to rapidly detect ocular trauma.[16]
In 2020, Pan and his team initiated the development of rapid tests for detecting COVID-19.[17][18] Within six months, they created their first test, followed by four more by the end of 2021.[19] Three tests, including the Antisense test, have been licensed for commercialization and registered with the Food and Drug Administration.[19] Later, he founded a company called VitruVian Bio to further develop the test for commercial applications.[20][21]
In 2023, Dipanjan Pan and his research team developed the first rapid test for mpox, as reported in the journal Advanced Functional Materials.[22] It uses a selective molecular sensor that can detect the virus within minutes.[22] The method employs nanomaterial heterostructures, consisting of zero-dimensional spherical gold nanoparticles and two-dimensional hafnium disulfide nanoplatelets, as building blocks to create a platform technology capable of detecting trace amounts of genetic material in biological samples.[22]
Awards and recognition
[edit]- 2014: Elected Fellow of the Royal Society of Chemistry[4]
- 2016: Nanomaterials Letter Researcher Award[4]
- 2016: Elected Fellow of AHA[23]
- 2018: Elected Fellow of ACC[24]
- 2018: Dean's Award[25]
- 2020: COVID-19 Hero Award[26]
- 2021: Maryland Industrial Partnerships (MIPS) Award[27]
- 2023: Elected Fellow of AIMBE[28]
Bibliography
[edit]- Nanomedicine: A Soft Matter Perspective
- Personalized Medicine with a Nanochemistry Twist: Nanomedicine
References
[edit]- ^ "Dipanjan Pan". 11 July 2022.
- ^ "Indian-Origins Among Researchers to Develop Portable Sensor to Quickly Detect Severe Eye Injury".
- ^ a b c "Professor Dipanjan Pan, PHD, FRSC, FAHA, FACC | - the Pan Research Group".
- ^ a b c d e f "Professor Dipanjan Pan".
- ^ "Pastries-like nanoparticles may help fight". ProQuest 469698166.
- ^ "Nanoparticles Can Detect Blood Clots". ProQuest 858466007.
- ^ "Tale of a teardrop: Pine eye specialist developing device that could signal disease".
- ^ "UMSOM bringing artificial blood product one step closer to reality | Maryland Daily Record". 6 February 2023.
- ^ "University of Maryland School of Medicine physician-scientist to lead high-budget research project to develop artificial blood". 6 February 2023.
- ^ "St. Louis biotech company moves to Baltimore to develop fake blood for real emergencies". Baltimore Sun. 23 September 2019.
- ^ "Rapid COVID-19 tests now available in some Maryland doctors' offices but questions about accuracy persist". Baltimore Sun. 8 September 2020.
- ^ Staff, Daily Record (June 23, 2022). "DIPANJAN PAN | Maryland Daily Record".
- ^ a b "Bee, scorpion and snake venom may hold cancer cure". CNN. 12 August 2014.
- ^ "Live Well: How to avoid 'brain freeze' from cold drinks and bee venom could help fight cancer". 15 August 2014.
- ^ "Vitamin C-detecting sensor could assess eye injuries on the spot". 10 December 2015.
- ^ "Color-changing sensor detects signs of eye damage in tears".
- ^ "Paper-based electrochemical sensor can detect COVID-19 in less than five minutes".
- ^ "Researchers develop experimental rapid COVID-19 test using nanoparticle technique".
- ^ a b "DIPANJAN PAN | Maryland Daily Record". 23 June 2022.
- ^ "Researchers develop experimental rapid COVID-19 test using nanoparticle technique: Advanced nanotechnology provides 'naked eye' visual detection of virus in 10 minutes".
- ^ "UMBC's Dipanjan Pan Develops Rapid Diagnostic Test for Virus Causing COVID-19 - UMBC: University of Maryland, Baltimore County". 9 June 2020.
- ^ a b c "First rapid test for mpox developed, tech adaptable for other emerging diseases | Penn State University". www.psu.edu.
- ^ "Fellow of the American Heart Association". University of Illinois Urbana-Champaign.
- ^ Communications, Grainger Engineering Office of Marketing and. "Pan elected Fellow of American College of Cardiology". bioengineering.illinois.edu.
- ^ Communications, Grainger Engineering Office of Marketing and. "Dipanjan Pan earns outstanding college of engineering research honor". bioengineering.illinois.edu.
- ^ Staff, Daily Record (June 23, 2022). "DIPANJAN PAN | Maryland Daily Record".
- ^ "UMBC Faculty, Alumni Entrepreneurs Receive Record Number Of MIPS Awards For Tech Collaborations - UMBC: University Of Maryland, Baltimore County". February 11, 2021.
- ^ "AIMBE" (PDF).
| Authority control databases: Academics |
|---|
- Pennsylvania State University faculty
- Indian emigrants to the United States
- Indian Institutes of Technology alumni
- Indian medical researchers
- Washington University in St. Louis fellows
- Washington University School of Medicine faculty
- University of Illinois Urbana-Champaign faculty
- University of Maryland, Baltimore County faculty